These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 11560253)
21. 2-Amino-3-methylimidazo[4,5-f]quinoline (IQ) promotes mouse hepatocarcinogenesis by activating transforming growth factor-β and Wnt/β-catenin signaling pathways. Xie XL; Wei M; Kakehashi A; Yamano S; Tajiri M; Wanibuchi H Toxicol Sci; 2012 Feb; 125(2):392-400. PubMed ID: 22094457 [TBL] [Abstract][Full Text] [Related]
22. Potential Molecular Targets of Statins in the Prevention of Hepatocarcinogenesis. Ridruejo E; Romero-Caími G; Obregón MJ; Kleiman de Pisarev D; Alvarez L Ann Hepatol; 2018; 17(3):490-500. PubMed ID: 29735800 [TBL] [Abstract][Full Text] [Related]
23. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha. Santoni-Rugiu E; Jensen MR; Thorgeirsson SS Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068 [TBL] [Abstract][Full Text] [Related]
24. Mechanism of the paradoxical, inhibitory effect of phenobarbital on hepatocarcinogenesis initiated in infant B6C3F1 mice with diethylnitrosamine. Lee GH; Ooasa T; Osanai M Cancer Res; 1998 Apr; 58(8):1665-9. PubMed ID: 9563480 [TBL] [Abstract][Full Text] [Related]
25. An acyclic retinoid, NIK-333, inhibits N-diethylnitrosamine-induced rat hepatocarcinogenesis through suppression of TGF-alpha expression and cell proliferation. Kagawa M; Sano T; Ishibashi N; Hashimoto M; Okuno M; Moriwaki H; Suzuki R; Kohno H; Tanaka T Carcinogenesis; 2004 Jun; 25(6):979-85. PubMed ID: 14742314 [TBL] [Abstract][Full Text] [Related]
26. High-saturate-fat diet delays initiation of diethylnitrosamine-induced hepatocellular carcinoma. Duan XY; Pan Q; Yan SY; Ding WJ; Fan JG; Qiao L BMC Gastroenterol; 2014 Nov; 14():195. PubMed ID: 25410681 [TBL] [Abstract][Full Text] [Related]
27. [Expression of transforming growth factor alpha and its relationship with HBV infection in hepatocellular carcinomas]. Yuan F; Huang P; Gao M; Gong H Zhonghua Bing Li Xue Za Zhi; 1999 Feb; 28(1):35-8. PubMed ID: 11869510 [TBL] [Abstract][Full Text] [Related]
28. Dissimilar frequency of hepatoblastomas and hepatic cystadenomas and adenocarcinomas arising in hepatocellular neoplasms of D2B6F1 mice initiated with N-nitrosodiethylamine and subsequently given Aroclor-1254, dichlorodiphenyltrichloroethane, or phenobarbital. Diwan BA; Ward JM; Kurata Y; Rice JM Toxicol Pathol; 1994; 22(4):430-9. PubMed ID: 7817132 [TBL] [Abstract][Full Text] [Related]
29. Liver regeneration and hepatocarcinogenesis in transforming growth factor-alpha-targeted mice. Russell WE; Kaufmann WK; Sitaric S; Luetteke NC; Lee DC Mol Carcinog; 1996 Mar; 15(3):183-9. PubMed ID: 8597531 [TBL] [Abstract][Full Text] [Related]
30. Beta-catenin mutations are frequent in hepatocellular carcinomas but absent in adenomas induced by diethylnitrosamine in B6C3F1 mice. Ogawa K; Yamada Y; Kishibe K; Ishizaki K; Tokusashi Y Cancer Res; 1999 Apr; 59(8):1830-3. PubMed ID: 10213486 [TBL] [Abstract][Full Text] [Related]
31. Collaboration between growth factors and diverse chemical carcinogens in hepatocarcinogenesis of transforming growth factor alpha transgenic mice. Takagi H; Sharp R; Takayama H; Anver MR; Ward JM; Merlino G Cancer Res; 1993 Sep; 53(18):4329-36. PubMed ID: 8364928 [TBL] [Abstract][Full Text] [Related]
32. Sustained hepatic expression of FoxM1B in transgenic mice has minimal effects on hepatocellular carcinoma development but increases cell proliferation rates in preneoplastic and early neoplastic lesions. Kalinina OA; Kalinin SA; Polack EW; Mikaelian I; Panda S; Costa RH; Adami GR Oncogene; 2003 Sep; 22(40):6266-76. PubMed ID: 13679865 [TBL] [Abstract][Full Text] [Related]
33. Inhibitory role of Smad7 in hepatocarcinogenesis in mice and in vitro. Wang J; Zhao J; Chu ES; Mok MT; Go MY; Man K; Heuchel R; Lan HY; Chang Z; Sung JJ; Yu J J Pathol; 2013 Aug; 230(4):441-52. PubMed ID: 23625826 [TBL] [Abstract][Full Text] [Related]
34. Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer development. Wu K; Ding J; Chen C; Sun W; Ning BF; Wen W; Huang L; Han T; Yang W; Wang C; Li Z; Wu MC; Feng GS; Xie WF; Wang HY Hepatology; 2012 Dec; 56(6):2255-67. PubMed ID: 22898879 [TBL] [Abstract][Full Text] [Related]
35. Autonomous growth in serum-free medium and production of hepatocellular carcinomas by differentiated hepatocyte lines that overexpress transforming growth factor alpha 1. Wu JC; Merlino G; Cveklova K; Mosinger B; Fausto N Cancer Res; 1994 Nov; 54(22):5964-73. PubMed ID: 7525051 [TBL] [Abstract][Full Text] [Related]